Last reviewed · How we verify

NCT03505697

The Effects of IMT on Exercise Capacity, Dyspnea and Lung Functions in LTx

Completed NA Last updated 23 April 2018
What this trial tests

NA trial testing inspiratory muscle training in Lung Transplant in 34 participants. Completed in 1 May 2017.

Timeline
1 April 2016
Primary endpoint
1 March 2017
1 May 2017

Quick facts

Lead sponsorIstanbul Medipol University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposetreatment
Enrollment34
Start date1 April 2016
Primary completion1 March 2017
Estimated completion1 May 2017

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 18 to 75, any sex, with Lung Transplant or Inspiratory Muscle Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inspiratory Muscle Training (IMT), which is used to strengthen the respiratory muscles, is one of the techniques used in PR. It is mostly used in patients with chronic obstructive pulmonary disease, and has been shown to be beneficial for functionality and also for relieving dyspnea perception. It is reported in the guidelines that IMT has additional benefit for endurance in COPD patients. However, there are no studies related to its use and effectiveness in lung transplantation. In this study, we hoped to increase these known benefits by adding IMT to the standard Pulmonary Rehabilitation. There are two main objectives of this study: 1. to examine the effect of respiratory muscle training on exercise capacity in lung transplantation candidates, 2. to compare dyspnea perception and lung function changes between the IMT+PR group and the PR group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of inspiratory muscle training

Trials testing the same drug.

Other recruiting trials for Lung Transplant

Currently open trials in the same condition.

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03505697.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing